Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1970 Aug;66(4):1298–1305. doi: 10.1073/pnas.66.4.1298

IMMUNOASSAY OF PLASMA VASOPRESSIN IN MAN

Gary L Robertson 1,2, Lester A Klein 1,2, Jesse Roth 1,2,*, Phillip Gorden 1,2
PMCID: PMC335819  PMID: 5273455

Abstract

A radioimmunoassay for arginine vasopressin has been developed that is sensitive to the hormone at 1 pg/ml. When plasma was filtered on G-25 Sephadex, immunoreactivity was detected in three regions. Endogenous arginine vasopressin was the third and smallest of the peaks and was recovered just after the salt. By combining gel filtration with immunoassay, we have made precise measurements of arginine vasopressin in a few milliliters of plasma.

Full text

PDF
1301

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACHER R., LIGHT A., DU VIGNEAUD V. Purification of oxytocin and vasopressin by way of a protein complex. J Biol Chem. 1958 Jul;233(1):116–120. [PubMed] [Google Scholar]
  2. HELLER J., STULC J. Význam nové metody titrace antidiuretického hormonu. Cesk Fysiol. 1959 Apr;8(3):194–195. [PubMed] [Google Scholar]
  3. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  4. Janson J. C. Adsorption phenomena on Sephadex. J Chromatogr. 1967 May;28(1):12–20. doi: 10.1016/s0021-9673(01)85920-3. [DOI] [PubMed] [Google Scholar]
  5. Manning M., Wuu T. C., Baxter J. W. The purification of synthetic oxytocin and analogues by gel filtration on Sephadex G-15. J Chromatogr. 1968 Dec 3;38(3):396–398. doi: 10.1016/0021-9673(68)85065-4. [DOI] [PubMed] [Google Scholar]
  6. Marks L. J., Berde B., Klein L. A., Roth J., Goonan S. R., Blumen D., Nabseth D. C. Inappropriate vasopressin secretion and carcinoma of the pancreas. Am J Med. 1968 Dec;45(6):967–974. doi: 10.1016/0002-9343(68)90196-4. [DOI] [PubMed] [Google Scholar]
  7. Melani F., Rubenstein A. H., Steiner D. F. Human serum proinsulin. J Clin Invest. 1970 Mar;49(3):497–507. doi: 10.1172/JCI106259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Roth J., Glick S. M., Klein L. A., Petersen M. J. Specific antibody to vasopressin in man. J Clin Endocrinol Metab. 1966 Jun;26(6):671–675. doi: 10.1210/jcem-26-6-671. [DOI] [PubMed] [Google Scholar]
  9. Roth J., Gorden P., Pastan I. "Big insulin": a new component of plasma insulin detected by immunoassay. Proc Natl Acad Sci U S A. 1968 Sep;61(1):138–145. doi: 10.1073/pnas.61.1.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Share L. Vasopressin, its bioassay and the physiological control of its release. Am J Med. 1967 May;42(5):701–712. doi: 10.1016/0002-9343(67)90090-3. [DOI] [PubMed] [Google Scholar]
  11. Wu W. H., Rockey J. H. Antivasopressin antibody. Characterization of high-affinity rabbit antibody with limited association constant heterogeneity. Biochemistry. 1969 Jul;8(7):2719–2728. doi: 10.1021/bi00835a005. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES